-
2025.03.05
O
n
c
o
L
a
B
Antibody-Conjugated NanoGel
for Therapeutic Platform
OncoLaB isan innovative biotech venture company that has developed the next-generation immuno-oncology treatment platform ANGel, which possesses excellent drug delivery, efficacy, and sustainability. The company was founded by CEO Jongseong Kim and CTO Doogie Oh, who have over 20 years of experience in nanogel research. We are developing therapeutic technologies for hard-to-treat cancers, including triple-negative breast cancer and various solid tumors, with the following technologies and visions
OncoLaB is always recruiting talent.
OncoLab is continuously hiring talented individuals in the field of biotechnology. Those interested in applying are encouraged to submit their documents via email.